Target intelligence / Profile preview

Rh family B glycoprotein (RHBG)

Target
RHBG
Molecular classification
Transporter, Solute carrier (SLC) family protein, Ammonium transporter (Amt/Mep/Rh family), Transmembrane protein
01

Overview

Rh family B glycoprotein (RHBG) is an ammonium transporter of the solute carrier family 42, mainly expressed in the kidney but also found in the liver, skin, and gastrointestinal tract[1][2][4]. It is a polytopic transmembrane protein with 12 predicted membrane-spanning domains[1][2][3], facilitating the electroneutral transport of ammonium (NH4⁺) and ammonia (NH3) across basolateral membranes of renal and epithelial cells[1][2]. RHBG contributes crucially to renal ammonia secretion, acid–base balance, and metabolic homeostasis[2][4]. It is regulated post-transcriptionally and interacts with cytoskeletal anchor proteins for correct membrane localization; loss of this function impairs ammonium transport[2]. Besides its transporter role, RHBG may act as a transceptor, linking cell signaling (including NFκB pathway) and metabolism, and has been studied for regulatory control by β-catenin/TCF4 signaling in malignancy contexts[2]. No direct therapeutic drugs are known to target RHBG, but its function is critical to renal and systemic pH homeostasis[1][2][4].

Other names
Ammonium transporter Rh type BSLC42A2Solute carrier family 42 member 2Rh type B glycoproteinRhesus blood group family type B glycoproteinmethylammonium-ammonium permease RhBGRhBG ammonium transporter
02

Mechanism of action

Ammonium transport inhibition or modulation (no clinical inhibitors described). Blockade of ammonium/H⁺ exchange. Disruption of membrane localization (via targeting ankyrin-G interaction).

03

Biological functions

Ammonium (NH4⁺) transportAmmonia (NH3) transportAcid–base homeostasisCO₂ transport (possible/minor)Cellular signaling via NFκB (as a transceptor)
04

Disease associations

Acid–base disorders (renal acid–base homeostasis)Hemolytic disease of fetus and newborn, Rh-induced (related family role)Overhydrated hereditary stomatocytosis (related family role)Cancer (dysregulation in hepatocellular and colon adenocarcinoma)Other (potential metabolic and signaling disorders)
05

Safety considerations

Disturbance of renal acid–base homeostasis if inhibitedPotential systemic metabolic acidosis or alkalosisImpact on pulmonary or hepatic ammonium metabolism

Beyond the preview

Go deeper on Rh family B glycoprotein (RHBG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rh family B glycoprotein (RHBG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call